The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee is scheduled to vote on June 10 on the safety and efficacy of evolocumab, an injectable medication to treat hyperlipidemia, mixed dyslipidemia and homozygous familial hypercholesterolemia.

New York Times columnist Abigail Zuger, MD, describes a quandary that many physicians face: trying to reconcile her professional judgment when in conflict with a patient’s former doctor. An ethicist offers some advice on care pathways.

Within 30 days of first taking statin and nonstatin lipid-lowering drugs (LLDs), patients were more likely have memory loss compared with a group that was not treated with any LLDs, according to a retrospective cohort study. When comparing statin and nonstatin users, there was no difference in memory loss.

The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee is scheduled to vote June 9 on the safety and effectiveness of the monoclonal antibody alirocumab as a treatment for patients with hypercholesterolemia.

An FDA advisory panel is considering two drugs that lower low-density lipoprotein (LDL) cholesterol, the Wall Street Journal reports. The injectable medications (evolocumab and alirocumab) are proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors and are expected to be used in patients who cannot tolerate statins or who failed with previous statin therapy.

Japanese patients who received chest-compression only CPR after an out-of-hospital cardiac arrest had an increase in survival with a favorable neurologic outcome, according to a nationwide observational study.

The scientific sessions by the American College of Cardiology and the Transcatheter Cardiovascular Therapies (TCT) arguably are the big dogs in cardiology-related conferences. Many consider them “can’t miss” events, but smaller venues offer benefits as well.

Hospitals and health systems are starting to pay attention to their online ratings and reviews. The push towards reputation management comes at a time when more patients are shopping for their medical care.